TMEM106B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.47150111277028E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.63980006929432E-11 |
Normal-vs-Stage2 |
1.128250E-02 |
Normal-vs-Stage3 |
4.39519999995142E-06 |
Normal-vs-Stage4 |
1.95454763485259E-12 |
Stage1-vs-Stage2 |
5.016800E-01 |
Stage1-vs-Stage3 |
5.557800E-01 |
Stage1-vs-Stage4 |
2.007700E-02 |
Stage2-vs-Stage3 |
3.690400E-01 |
Stage2-vs-Stage4 |
1.084810E-01 |
Stage3-vs-Stage4 |
4.929400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.95339991246624E-10 |
Normal-vs-AfricanAmerican |
2.27995400337022E-12 |
Normal-vs-Asian |
1.631680E-02 |
Caucasian-vs-AfricanAmerican |
3.282500E-03 |
Caucasian-vs-Asian |
9.920000E-01 |
AfricanAmerican-vs-Asian |
2.078200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.29009955233073E-10 |
Normal-vs-Female |
3.3104996521871E-10 |
Male-vs-Female |
9.032000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.00460000318492E-08 |
Normal-vs-Age(41-60Yrs) |
2.38310005062914E-09 |
Normal-vs-Age(61-80Yrs) |
4.67289995587095E-09 |
Normal-vs-Age(81-100Yrs) |
2.90389999824114E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.352210E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.960580E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.334200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.573800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.696770E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.958100E-03 |
Normal-vs-Grade 2 |
4.80150000004009E-06 |
Normal-vs-Grade 3 |
5.94213567239876E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
7.956400E-01 |
Grade 1-vs-Grade 3 |
5.498000E-01 |
Grade 1-vs-Grade 4 |
1.907890E-02 |
Grade 2-vs-Grade 3 |
1.249830E-01 |
Grade 2-vs-Grade 4 |
8.41129999999968E-05 |
Grade 3-vs-Grade 4 |
3.368000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.37910000051068E-07 |
Normal-vs-ccB subtype |
1.09110000001689E-06 |
ccA subtype-vs-ccB subtype |
3.880800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.55200000032607E-07 |
Normal-vs-N1 |
1.564850E-04 |
N0-vs-N1 |
3.459800E-01 |
|
|